Grifols in talks to sell minority stake of Shanghai RAAS Blood Products to China Merchants Group, following the impasse in the agreement with China Resources Holdings
Grifols negociaría la venta de una participación minoritaria de Shanghai RAAS Blood Products a China Merchants Group tras el estancamiento del acuerdo con China Resources Holdings
Intel ID : 381195
|
Intel ID | 381195 | ||||
Value | ND | ||||
Native Currency | Euro (EUR) | ||||
Financial Data - Grifols
(31 Dec 2023) |
Revenue: EUR 7.077,97m EBITDA: EUR 1.247,56m Net Debt: EUR 10.541,45m |
||||
Date |
![]() |
||||
Country | ![]() |
||||
Geography | ![]() |
||||
Subsector (Old TTR Sectors) |
|
||||
Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 25.04.03 Holding Companies / Financial Holding Companies (Primary) 25 Financial Services / 25.04 Other Financial Services |
||||
Type |
![]() |
||||
Intel Grade |
![]() |
||||
Source |
![]() |
||||
Tags | ![]() |
Bidder
Name |
|
|||
Subsector (Old TTR Sectors) |
|
|||
Country |
![]() |
|||
Website |
![]() |
|||
Description |
![]() |
Target
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Seller
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Related Entity
Name |
|
||
Subsector (Old TTR Sectors) |
|
||
Primary Sector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services |
||
Country |
![]() |
||
Website |
![]() |
||
Description |
![]() |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.